Source - SMW
Biotech Growth Trust said it has noted that the General Partners of OrbiMed Capital, which acts as portfolio manager to the Company, released a statement late on 5 December concerning Founding Partner Samuel Isaly, who is the subject of a press article containing allegations of harassment.

Samuel Isaly denies the allegations. OrbiMed is retaining the services of an outside independent law firm to investigate the matter.

The Board remains closely in touch with OrbiMed and will keep shareholders informed of any relevant developments.




At 1:45pm: (LON:BIOG) Biotech Gwth share price was -19.5p at 735.25p